Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elizabeth Hougen Insider Profile
4 Followers
Elizabeth Hougen, EVP, Finance & CFO at Ionis Pharmaceuticals, holds 92.91K shares in Ionis Pharmaceuticals (Ticker: IONS).
Elizabeth Hougen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Elizabeth Hougen's holdings
Insider Roles
EVP, Finance & CFO
Roles that Elizabeth Hougen holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 07, 2023 - Feb 07, 2024
Return:-20.90%
The most profitable trade made by Elizabeth Hougen
Elizabeth Hougen's Trading History
List of latest transactions for each holding click on a transaction to see Elizabeth Hougen's performance on stock
You May Also Like
Elizabeth Hougen insider profile FAQ
What is the percentage of profitable transactions made by Elizabeth Hougen?
The percentage of profitable transactions made by Elizabeth Hougen is ―.
What is the average return per transaction made by Elizabeth Hougen?
The average return per transaction made by Elizabeth Hougen is ―.
What stocks does Elizabeth Hougen hold?
Elizabeth Hougen holds: IONS stocks.
What was Elizabeth Hougen’s latest transaction?
Elizabeth Hougen latest transaction was an Uninformative Buy of ―.
What was Elizabeth Hougen's most profitable transaction?
Elizabeth Hougen’s most profitable transaction was an Informative Sell of IONS stock on February 7, 2023. The return on the trade was -20.90%.
What is Elizabeth Hougen's role in Ionis Pharmaceuticals?
Elizabeth Hougen's role in Ionis Pharmaceuticals is EVP, Finance & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.